⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 18, 2024Open Access

Table S3 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

Julia Judd Nagla Abdel Karim Hina Khan Abdul Rafeh Naqash Yasmine Baca Joanne Xiu Ari M. Vanderwalde Hirva Mamdani Luis E. Raez Misako Nagasaka Sachin Gopalkrishna Pai Mark A. Socinski Jorgé Nieva Chul Kim Antoinette J. Wozniak Chukwuemeka Ikpeazu Gilberto Lopes Alexander I. Spira W. Michael Korn Edward S. Kim Stephen V. Liu Hossein Borghaei

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplemental Table 3. Mutation rates of key biomarkers in KRAS mutated NSCLC cohorts

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Judd et al. (2024) studied this question.

synapsesocial.com/papers/68e64524b6db6435875d6265 https://doi.org/10.1158/1535-7163.26058192.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S3 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024
2Table S4 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024
3Table S4 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024
4Figure S1 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024
5Table S2 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024

More related papers

Table S2 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024
Table S1 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024
Table S1 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer2024